Can the Prediction Market Improve Predictions of COVID-19?
1 other identifier
interventional
560
1 country
1
Brief Summary
The goal of this study is to better understand how people predict the future risks of the novel Coronavirus (COVID-19). Specifically, the investigators will ask the following research questions:
- How well do participants predict the future risks of COVID-19?
- Can the predictions be improved by using a prediction market mechanism?
- Does the prediction market reduce people's fear of COVID-19?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2020
CompletedFirst Submitted
Initial submission to the registry
May 27, 2020
CompletedFirst Posted
Study publicly available on registry
June 1, 2020
CompletedJune 2, 2020
May 1, 2020
1 day
May 27, 2020
May 30, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Predictions of COVID-19 Cases and Deaths
Participants are asked 16 questions of the following format: "What do you think will be the total cumulative number of cases in Singapore on 8th of June, at 12pm?" Each question has 5 answer options. Each answer option is a range of possible outcomes. The primary outcome measure is participants' perceived likelihood of each answer option. The 16 questions come from the following variations: 4 countries (Mexico, Singapore, Turkey, USA) x 2 outcome measures (cases, deaths) x 2 time periods (8th of June, 6th of July).
24 hours
Secondary Outcomes (1)
Fear
24 hours (participants are required to submit post-experiment survey within 24 hours of completion of the main experiment)
Study Arms (2)
Control
NO INTERVENTIONParticipants' COVID-19 predictions are elicited via a survey
Treatment
EXPERIMENTALParticipants' COVID-19 predictions are elicited via a prediction market
Interventions
Participants "bet" on likely future outcomes using a prediction market
Eligibility Criteria
You may qualify if:
- National University of Singapore students
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University of Singapore
Singapore, Singapore
Related Publications (1)
Camerer CF, Dreber A, Holzmeister F, Ho TH, Huber J, Johannesson M, Kirchler M, Nave G, Nosek BA, Pfeiffer T, Altmejd A, Buttrick N, Chan T, Chen Y, Forsell E, Gampa A, Heikensten E, Hummer L, Imai T, Isaksson S, Manfredi D, Rose J, Wagenmakers EJ, Wu H. Evaluating the replicability of social science experiments in Nature and Science between 2010 and 2015. Nat Hum Behav. 2018 Sep;2(9):637-644. doi: 10.1038/s41562-018-0399-z. Epub 2018 Aug 27.
PMID: 31346273BACKGROUND
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Teck Ho, PhD
National University of Singapore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Deputy President & Provost
Study Record Dates
First Submitted
May 27, 2020
First Posted
June 1, 2020
Study Start
May 15, 2020
Primary Completion
May 16, 2020
Study Completion
May 17, 2020
Last Updated
June 2, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- After completion of all analysis. It will be made available in the supporting documentation.
- Access Criteria
- It will be made available in the supporting documentation.
Investigators will not be storing or sharing any personal identifiers. All individual level data will be anonymized, and only anonymized data will be shared with other researchers, upon request.